Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects
Clinical trial NCT02415790 · COMPLETED
Trial details
- NCT number
- NCT02415790
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-06-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.